|
SPOPL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.754800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.206200E-01 |
| Normal-vs-Stage2 |
3.054000E-01 |
| Normal-vs-Stage3 |
2.007200E-01 |
| Normal-vs-Stage4 |
1.203670E-02 |
| Stage1-vs-Stage2 |
7.440200E-01 |
| Stage1-vs-Stage3 |
6.723200E-03 |
| Stage1-vs-Stage4 |
2.558600E-04 |
| Stage2-vs-Stage3 |
9.359900E-02 |
| Stage2-vs-Stage4 |
1.990010E-02 |
| Stage3-vs-Stage4 |
2.717800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.557600E-01 |
| Normal-vs-AfricanAmerican |
2.610000E-02 |
| Normal-vs-Asian |
3.041400E-01 |
| Caucasian-vs-AfricanAmerican |
6.535300E-03 |
| Caucasian-vs-Asian |
5.934200E-01 |
| AfricanAmerican-vs-Asian |
7.519800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.891400E-01 |
| Normal-vs-Female |
4.331000E-01 |
| Male-vs-Female |
2.599800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.329000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.282800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.673400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.881600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.654200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.114000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.814400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.120800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.049200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.552400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.016970E-01 |
| Normal-vs-Grade 2 |
4.065800E-02 |
| Normal-vs-Grade 3 |
5.247600E-01 |
| Normal-vs-Grade 4 |
8.07620000000675E-05 |
| Grade 1-vs-Grade 2 |
7.965600E-01 |
| Grade 1-vs-Grade 3 |
1.251150E-01 |
| Grade 1-vs-Grade 4 |
1.062820E-03 |
| Grade 2-vs-Grade 3 |
5.355800E-03 |
| Grade 2-vs-Grade 4 |
2.1117000037485E-08 |
| Grade 3-vs-Grade 4 |
3.645300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.639200E-04 |
| Normal-vs-ccB subtype |
1.635360E-01 |
| ccA subtype-vs-ccB subtype |
4.64209999995191E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.739000E-01 |
| Normal-vs-N1 |
2.328800E-01 |
| N0-vs-N1 |
1.658020E-01 |
|
|
